Insight Molecular Diagnostics Inc. (IMDX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 32K | 1.14M | 260K | 518K | 2.14M | 1.49M | 115K | 104K | 176K | 314K | 429K | 463K |
| Revenue Growth % | -98.5% | -23.35% | 126.09% | 398.08% | 1114.77% | 373.25% | -73.19% | -77.54% | -40.74% | 14.6% | 540.3% | 95.36% |
| Cost of Goods Sold | 637.5K | 643K | 121K | 168K | 813K | 891K | 65K | 54K | 131K | 409K | 181K | 191K |
| COGS % of Revenue | 1992.19% | 56.45% | 46.54% | 32.43% | 38.03% | 59.96% | 56.52% | 51.92% | 74.43% | 130.25% | 42.19% | 41.25% |
| Gross Profit | -605.5K | 496K | 139K | 350K | 1.32M | 595K | 50K | 50K | 45K | -95K | 248K | 272K |
| Gross Margin % | -1892.19% | 43.55% | 53.46% | 67.57% | 61.97% | 40.04% | 43.48% | 48.08% | 25.57% | -30.25% | 57.81% | 58.75% |
| Gross Profit Growth % | -145.7% | -16.64% | 178% | 600% | 2844.44% | 726.32% | -79.84% | -81.62% | 350% | -2275% | 192.19% | 777.42% |
| Operating Expenses | 9.73M | 10.45M | 11.19M | 10.19M | 8.12M | 34.22M | 13.56M | 4.68M | 9.31M | 16.08M | 6.76M | 8.57M |
| OpEx % of Revenue | 30392.19% | 917.12% | 4302.69% | 1967.57% | 379.98% | 2302.96% | 11795.65% | 4501.92% | 5290.91% | 5122.29% | 1575.99% | 1850.11% |
| Selling, General & Admin | 5.39M | 4.38M | 3.93M | 4.11M | 4.32M | 3.4M | 3.61M | 3.26M | 3.46M | 2.39M | 3.18M | 3.85M |
| SG&A % of Revenue | 16853.13% | 384.72% | 1511.92% | 792.86% | 202.1% | 228.67% | 3137.39% | 3134.62% | 1965.91% | 761.47% | 741.96% | 832.61% |
| Research & Development | 4.6M | 5.83M | 3.88M | 3.28M | 2.92M | 2.26M | 2.82M | 2.45M | 2.31M | 2.55M | 2.19M | 2.44M |
| R&D % of Revenue | 14375% | 511.76% | 1491.54% | 633.4% | 136.76% | 151.88% | 2449.57% | 2358.65% | 1313.64% | 811.15% | 509.32% | 525.92% |
| Other Operating Expenses | -267.5K | 235K | 1000K | 1000K | 879K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -10.33M | -9.95M | -11.05M | -9.84M | -6.8M | -33.63M | -13.52M | -4.63M | -9.27M | -16.18M | -6.51M | -8.29M |
| Operating Margin % | -32284.38% | -873.57% | -4249.23% | -1900% | -318.01% | -2262.92% | -11752.17% | -4453.85% | -5265.34% | -5152.55% | -1518.18% | -1791.36% |
| Operating Income Growth % | -51.95% | 70.41% | 18.25% | -112.48% | 26.63% | -107.84% | -107.51% | 44.15% | -258.41% | -38.9% | -281.77% | -410.09% |
| EBITDA | -9.7M | -9.39M | -10.46M | -9.28M | -6.31M | -33.06M | -13.18M | -4.31M | -8.93M | -15.85M | -6.09M | -7.84M |
| EBITDA Margin % | -30312.5% | -824.14% | -4024.62% | -1792.08% | -295.04% | -2225.03% | -11456.52% | -4140.38% | -5075% | -5049.04% | -1418.88% | -1692.66% |
| EBITDA Growth % | -53.77% | 71.61% | 20.58% | -115.58% | 29.38% | -108.55% | -116.44% | 45.06% | -241.28% | -52.88% | -1695.58% | -2846.24% |
| D&A (Non-Cash Add-back) | 631K | 563K | 584K | 559K | 491K | 563K | 340K | 326K | 335K | 325K | 426K | 457K |
| EBIT | -10.33M | -22.93M | -10.82M | -9.72M | -6.64M | -33.48M | -13.46M | -4.52M | -9.11M | -5.06M | -6.47M | -8.32M |
| Net Interest Income | -23K | -26K | -29K | -25K | -29K | -30K | -31K | -8K | -15K | -160K | -14K | -14K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 23K | 26K | 29K | 25K | 29K | 30K | 31K | 8K | 15K | 160K | 14K | 14K |
| Other Income/Expense | 6.04M | -13.01M | 194K | 100K | 128K | 116K | 22K | 102K | 138K | 187K | 24K | -39K |
| Pretax Income | -4.29M | -22.95M | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M | -9.13M | -15.99M | -6.49M | -8.33M |
| Pretax Margin % | -13406.25% | -2015.36% | -4174.62% | -1880.7% | -312.02% | -2255.11% | -11733.04% | -4355.77% | -5186.93% | -5092.99% | -1512.59% | -1799.78% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -4.29M | -22.95M | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M | -9.13M | -15.99M | -6.49M | -8.33M |
| Net Margin % | -13406.25% | -2015.36% | -4174.62% | -1880.7% | -312.02% | -2255.11% | -11733.04% | -4355.77% | -5186.93% | -5092.99% | -1512.59% | -1799.78% |
| Net Income Growth % | 35.69% | 31.5% | 19.56% | -115.06% | 26.93% | -109.55% | -107.94% | 45.64% | -400.99% | 64.44% | 30.47% | -0.4% |
| Net Income (Continuing) | -4.29M | -22.95M | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M | -9.13M | -15.99M | -6.49M | -8.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.12 | -0.75 | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 | -1.13 | -1.96 | -0.81 | -1.07 |
| EPS Growth % | 53.77% | 61.1% | 65.44% | 14.65% | 77.03% | 1.64% | -21.47% | 66.69% | -382.5% | 74.35% | 49.06% | 23.57% |
| EPS (Basic) | -0.12 | -0.75 | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 | -1.13 | -1.96 | -0.81 | -1.07 |
| Diluted Shares Outstanding | 34.52M | 30.48M | 32.03M | 32.02M | 25.69M | 17.38M | 13.71M | 12.87M | 8.26M | 8.26M | 8.26M | 8.09M |
| Basic Shares Outstanding | 34.52M | 30.48M | 32.03M | 32.02M | 25.69M | 17.38M | 13.71M | 12.87M | 8.26M | 8.26M | 8.26M | 8.09M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |